pharmaphorum4d
GSK says new inhaler will help slash its carbon footprint
The first phase 3 trials are due to start in the first half of next year, using devices manufactured at GSK’s facility in Evreux, France. “If successful, this could lead to regulatory ...
Hosted on MSN1mon
GSK Launches $2.5 Billion Buyback, Raises Midterm Sales Outlook
GSK plans to buy back $2.50 billion in shares and raised its midterm sales target, citing promising pipeline developments. The British pharmaceutical company said Wednesday that its pipeline ...
New York Post5d
FDA greenlights GSK’s drug for UTIs in women and girls
The Food and Drug Administration on Tuesday approved GSK’s drug for a common type of urinary tract infection (UTI) in women and adolescent girls, one of five new approvals the British drugmaker ...